Of note, a recently published retrospective study evaluated a total of 3077 patients with NSCLC who underwent molecular analysis by NGS, identifying 46 cases (1.5%) of co-occurring gene alterations, most (80%) involving EGFR mutations [28]. Here, EGFR is linked to non-small cell lung carcinoma.